We're currently experiencing extremely high call volumes. We're very sorry for any inconvenience this might cause. If you need help with your account, please visit our Help Centre, or email us and we’ll get back to you as soon as we can. For more information and tips on managing your account online please visit www.hl.co.uk/coronavirus

We’re experiencing high call volumes, please check FAQs before calling.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Boston Scientific (BSX) Com Stk US $0.01

Sell:$36.90 Buy:$36.91 Change: $1.78 (5.07%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$36.90
Buy:$36.91
Change: $1.78 (5.07%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$36.90
Buy:$36.91
Change: $1.78 (5.07%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

Contact details

Address:
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
01752-1234
United States
Telephone:
+1 (508) 6834000
Website:
https://www.bostonscientific.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BSX
ISIN:
US1011371077
Market cap:
$49.15 billion
Shares in issue:
1.40 billion
Sector:
Health Care Equipment
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Michael Mahoney
    Chairman of the Board, President, Chief Executive Officer
  • Daniel Brennan
    Chief Financial Officer, Executive Vice President
  • Kevin Ballinger
    Executive Vice President and Global President - Interventional Cardiology
  • Arthur Butcher
    Executive Vice President and President, Asia Pacific
  • Joseph Fitzgerald
    Executive Vice President and President - Rhythm Management
  • Edward Mackey
    Executive Vice President - Operations
  • Ian Meredith
    Executive Vice President, Global Chief Medical Officer
  • Jeffrey Mirviss
    Executive Vice President and President - Peripheral Interventions
  • David Pierce
    Executive Vice President and President, MedSurg and President, Endoscopy
  • Eric Thepaut
    Executive Vice President and President - Europe, Middle East and Africa

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.